|
J Biol Chem, Vol. 274, Issue 28, 19943-19948, July 9, 1999
Angiotensin II Negatively Modulates L-type Calcium Channels
through a Pertussis Toxin-sensitive G Protein in Adrenal Glomerulosa
Cells*
Andrés D.
Maturana §,
Andrés J.
Casal ,
Nicolas
Demaurex¶,
Michel B.
Vallotton ,
Alessandro M.
Capponi , and
Michel F.
Rossier **
From the Division of Endocrinology and Diabetology,
Department of Internal Medicine, the Laboratory of Clinical
Chemistry, Department of Pathology, the ¶ Department of
Physiology, and the § Fondation pour Recherches
Médicales, University Hospital, 24 rue
Micheli-du-Crest,CH-1211 Geneva 14, Switzerland
 |
ABSTRACT |
In bovine adrenal glomerulosa cells, angiotensin
II and extracellular K+ stimulate aldosterone
secretion in a calcium-dependent manner. In these cells,
physiological concentrations of extracellular potassium activate both
T-type (low threshold) and L-type (high threshold) voltage-operated
calcium channels. Paradoxically, the cytosolic calcium response to 9 mM K+ is inhibited by angiotensin II. Because
K+-induced calcium changes observed in the cytosol are
almost exclusively due to L-type channel activity, we therefore studied
the mechanisms of L-type channel regulation by angiotensin II. Using
the patch-clamp method in its perforated patch configuration, we
observed a marked inhibition (by 63%) of L-type barium currents in
response to angiotensin II. This effect of the hormone was completely
prevented by losartan, a specific antagonist of the AT1
receptor subtype. Moreover, this inhibition was strongly reduced when
the cells were previously treated for 1 night with pertussis toxin. An
effect of pertussis toxin was also observed on the modulation by
angiotensin II of the K+ (9 mM)-induced
cytosolic calcium response in fura-2-loaded cells, as well as on the
angiotensin II-induced aldosterone secretion, at both low (3 mM) and high (9 mM) K+
concentrations. Finally, the expression of both Go and
Gi proteins in bovine glomerulosa cells was detected by
immunoblotting. Altogether, these results strongly suggest that in
bovine glomerulosa cells, a pertussis toxin-sensitive G protein is
involved in the inhibition of L-type channel activity induced by
angiotensin II.
 |
INTRODUCTION |
Angiotensin II (AngII)1
and potassium ion (K+) are the major regulators of calcium
influx into adrenal glomerulosa cells, a crucial step in the
stimulation of aldosterone production. Both stimuli are able to
maintain a sustained influx of Ca2+ into these cells. AngII
induces a biphasic response of the cytosolic free Ca2+
concentration ([Ca2+]c): an initial transient
rise due to inositol 1,4,5-trisphosphate-induced release of
Ca2+ from the intracellular stores is followed by a
sustained plateau phase, resulting from the activation of the
capacitative influx triggered by the depletion of intracellular
Ca2+ pools (1, 2). Angiotensin II also activates
voltage-operated Ca2+ channels of both T- and L-types by
inducing cell depolarization through inhibition of K+
channels. Ca2+ influx through these channels also
contributes to the sustained Ca2+ entry triggered by AngII
(1). Extracellular K+, by depolarizing the cells, directly
activates the voltage-operated Ca2+ channels, leading to a
sustained Ca2+ entry into the cell (3, 4). Paradoxically,
Ca2+ entry elicited by K+ is markedly inhibited
upon addition of AngII (5, 6). Although this phenomenon was observed
some years ago both in rat and bovine glomerulosa cells, the mechanism
of this AngII effect on cytosolic Ca2+ homeostasis has
never been elucidated.
In bovine glomerulosa cells, the presence of both high threshold, long
lasting (L-type) and low threshold, transient (T-type) voltage-operated
Ca2+ channels has been demonstrated (7). Because of their
low threshold of activation, T-type channels have been first thought to
be the major mediators of the Ca2+ response to
physiological increases of extracellular K+ (3, 8). Various
laboratories have subsequently investigated the modulation of T-type
channels by AngII, but contradictory results have been published. Lu
et al. (9) have observed an increase of T channel activity
induced by AngII and mediated by a Gi protein. In fact,
they have shown that AngII shifts the activation curve of T channels to
more negative voltage values, increasing the size of the permissive
window of voltage of the channel and therefore allowing more
Ca2+ to enter the cell in a steady state manner. In
contrast, in our laboratory, we found that AngII shifts the activation
curve of T channels to more positive voltages, thus reducing the
steady-state current through these channels (10). In this study,
Rossier et al. (10) demonstrated that AngII exerts a
negative modulation on T channels and that this modulation is mediated
by protein kinase C (PKC). In summary, both positive and negative
effects of AngII on T channel activity have been observed in
electrophysiological experiments performed under similar conditions,
but no correlation with [Ca2+]c has been ever obtained.
Recently, a clear dissociation between L- and T-type channel functions
has been established. Indeed, Ca2+ entering through each
channel appears to have distinct functions and destinations (11).
Selective inhibition of L-type channels does not markedly affect
steroidogenesis, as demonstrated by Barrett et al. (12) with
the spider toxin -agatoxin-IIIA, as well as in our own laboratory,
using low concentrations of dihydropyridines (13). In contrast, in
these and other studies, T-type channel activity has been shown to be
more closely related to aldosterone production. For example, T channel
inhibition with the divalent ion nickel or the relatively specific
alkaloid tetrandrine strongly reduced aldosterone production (14).
Moreover, L-type channels appear to be the major mediators of the large
[Ca2+]c variations observed with fluorescent
probes in response to extracellular K+, whereas at low,
physiological concentrations of the agonist, the cytosolic
Ca2+ signal resulting from T channel activation is barely
detectable (15).
In order to understand the mechanism of the inhibition by AngII of the
K+-induced cytosolic Ca2+ response, we
therefore have investigated the modulation of the activity of L-type
channels by the hormone, using both patch-clamp and microfluorometry methods.
 |
EXPERIMENTAL PROCEDURES |
Percoll was obtained from Amersham Pharmacia Biotech.
Amphotericin B, nifedipine, nicardipine, phenylmethylsulfonyl fluoride, Triton X-100, aprotinin, leupeptin, 2-mercaptoethanol, pertussis toxin,
and tetrodotoxin were purchased from Sigma; fura-2 acetoxymethyl ester
was from Molecular Probes (Eugene, OR); Tween-20 was from Merck
(Geneva, Switzerland); glycerol and bromphenol blue were from Fluka
(Buchs, Switzerland); and Cell-Tak was from BioReba (Basel,
Switzerland). Losartan (DuP753) was a generous gift from Dr. R. D. Smith, DuPont Merck Pharmaceutical Co. Rabbit polyclonal antibodies
selectively raised against rat Gi and Go
proteins were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Adrenal Glomerulosa Cell Isolation and Culture--
Bovine
adrenal glands were obtained from a local slaughterhouse, and adrenal
glomerulosa cells were prepared by enzymatic dispersion, purified on a
Percoll density gradient, and, for the patch-clamp and microfluorometry
experiments, maintained in culture for 2-4 days on Cell-Tak-coated
glass coverslips, as described previously in detail (14). Otherwise,
cells were used freshly prepared, after two washes in Krebs-Ringer
buffer (137 mM NaCl, 1.8 mM KCl, 1.2 mM KH2PO4, 1.25 mM
MgSO4, 5 mM NaHCO3, 1.2 mM CaCl2, 5.5 mM
D-glucose, 20 mM Hepes, pH 7.4) for
[Ca2+]c measurements in cell populations.
Patch-clamp Measurements--
The activity of voltage-operated
Ca2+ channels in single bovine adrenal glomerulosa cells
was recorded under voltage-clamp in the perforated patch configuration
of the patch-clamp method, as described previously (13, 16). The bath
solution contained 117 mM tetraethylammonium chloride, 20 mM BaCl2, 0.5 mM MgCl2, 5 mM D-glucose, 32 mM sucrose, and
200 nM tetrodotoxin and was buffered to pH 7.5 with 10 mM Hepes (CsOH). The patch-pipette (3-6 megohm; Clark
150T, Reading, United Kingdom) contained 130 mM CsCl, 5 mM MgCl2, and 1 mM
CaCl2, and the pH was adjusted to 7.2 with 20 mM Hepes (CsOH). The pipette solution also contained 0.24 mg/ml amphotericin B, but the tip of the pipette was filled with
ionophore-free solution to allow the formation of the seal. The access
resistance was reduced within approximately 10 min after seal
formation. The reference electrode was placed in a KCl solution linked
to the bath with an Agar bridge, reducing the liquid junction potential
to negligible values. The cell was voltage-clamped (Axopatch 1D, Axon
Instruments, Foster City, CA) at holding potential of 90 mV and
depolarized as indicated. The currents were filtered at 1-2 kHz and
sampled at 5 kHz using a TL-1-125 interface (Axon Instruments). The
leak was subtracted automatically by a P/4 protocol (pclamp6, Axon Instruments).
Cytosolic Free Calcium Measurements--
Cytosolic
[Ca2+] was determined in freshly isolated bovine
glomerulosa cell populations loaded with the fluorescent probe fura-2. After isolation, cells were preincubated at 37 °C for approximately 1 h in Krebs-Ringer buffer. Cells were then washed, resuspended at
107 cells/ml, and incubated in the dark in the same buffer
for 45 min in the presence of 2 µM fura-2 acetoxymethyl
ester. Dye excess was then washed away and the cells were kept in the
dark at room temperature. Samples of 2 × 106 cells
were sedimented just before use and resuspended in 2 ml of Krebs-Ringer
buffer in a cuvette placed in a thermostatted room at 37 °C. Fura-2
fluorescence was recorded with a Jasco CAF-110 fluorescence
spectrometer (Hachioji City, Japan), and [Ca2+]c
was determined as described by Grynkiewicz et al. (17).
Cytosolic [Ca2+] was also determined in single cultured
cells, plated on glass coverslips coated with Cell-Tak. Cells were
incubated in a Krebs-Ringer buffer for 45 min at room temperature in
the presence of 1 µM fura-2 acetoxymethyl ester. Loaded
cells were then washed with the Krebs-Ringer buffer. Fura-2
fluorescence was monitored on an inverted Zeiss Axiovert S100TV
microscope coupled to a PTI D104 photometer. The light source came from
a Xenon XBO 75-W lamp. The fluorescent signal (excitation 340/380 nm,
emission 510 nm) was recorded using the Felix 1.1 software on an AST
386/100 MHz computer.
Determination of Aldosterone Production--
Measurement of
aldosterone production from cultured glomerulosa cells was performed as
described elsewhere (1). Glomerulosa cells, after 2 days in culture,
were incubated overnight in the presence or absence of pertussis toxin
(500 ng/ml). The next day, the medium was removed, and cells were
incubated for 1 h at 37 °C in multiwell plates containing a
modified Krebs-Ringer medium and various concentrations of AngII. At
the end of the incubation period, the aldosterone content of the medium
was determined by direct radioimmunoassay, using a commercially
available kit (Diagnostic Systems Laboratories, Webster, TX).
Extraction and SDS-PAGE Separation of Proteins--
Bovine
glomerulosa cells in primary culture, as well as cultured
GH4 cells, were homogenized in lysis buffer (containing 10 mM sodium phosphate, pH 7.4, 150 mM NaCl, 1%
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM
phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, and 1 µg/ml
leupeptin) at 4 °C. Extracted proteins were quantified using a
protein microassay (Bio-Rad). SDS-PAGE was performed according to the
method of Laemmli (18). Extracts of total cellular protein (16 µg/lane) were solubilized in sample buffer (60 mM
Tris-HCl, pH 6.8, 2% (w/v) SDS, 5% (v/v) 2-mercaptoethanol, 10%
(v/v) glycerol, and 0.01% (v/v) bromphenol blue) and loaded onto a
SDS/polyacrylamide (10%) gel (MiniProtean II system, Bio-Rad). Electrophoresis was performed at 130 V for 1 h.
Blotting and Immunodetection of G
Proteins--
SDS-PAGE-resolved proteins were electrophoretically
transferred onto a nitrocellulose membrane (Macherey-Nagel, Düen,
Germany). The membrane was then incubated in blocking buffer
(phosphate-buffered saline containing 0.4% Tween-20 and 5% nonfat
dried milk) overnight at 4 °C and then incubated for 1 h in
phosphate-buffered saline containing 0.4% Tween-20 with rabbit
polyclonal antibodies raised against the subunits of the
Go and Gi proteins. The membrane was washed
with the same buffer and then incubated for 1 h with horseradish
peroxidase-labeled goat anti-rabbit IgG (CovalAb, Oullins, France). The
membrane was then washed three times for 10 min with phosphate-buffered
saline containing 0.4% Tween-20, and the antigen-antibody complex was
revealed by enhanced chemiluminescence using a Western blot detection
kit and Hyper-ECL film (Amersham Pharmacia Biotech).
 |
RESULTS |
Inhibition by Angiotensin II of the Cytosolic Calcium Response
Induced by Potassium--
As previously observed in bovine glomerulosa
cells (5) and confirmed by others in rat cells (6), 10 nM
AngII markedly reduced the sustained elevation of
[Ca2+]c elicited upon addition of 9 mM extracellular K+ (Fig.
1A). Because challenge with
AngII is normally accompanied by Ca2+ release from inositol
,4,5-trisphosphate-sensitive intracellular Ca2+ pools and
by development of a capacitative Ca2+ influx, thapsigargin,
an inhibitor of the microsomal
Ca2+/Mg2+-ATPases, was added at the beginning
of the experiment in order to empty Ca2+ stores and to
allow an accurate determination of the inhibition of the
Ca2+ signal by the hormone. The amount of this inhibition
was estimated to be 63 ± 15% from 12 independent experiments.
The addition of 2 µM nifedipine, a dihydropyridine
antagonist, at the end of the experiment achieved to reduce
[Ca2+]c down to the level corresponding to 100%
inhibition of the voltage-operated Ca2+ channels.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Inhibition of the potassium-induced cytosolic
calcium response by angiotensin II. A, fura-2-loaded
cells were sequentially exposed to 200 nM thapsigargin
(Tg), 9 mM KCl, 10 nM AngII, and 2 µM nifedipine. Cytosolic Ca2+ values were
calculated as described under "Experimental Procedures."
Dotted lines represent maximal and minimal
[Ca2+]c values measured before and after complete
inhibition of voltage-operated calcium channels, respectively.
B, same experiment as in A, but the addition of
nifedipine and AngII was inverted. Traces are representative of 12 experiments yielding similar results.
|
|
Two mechanisms could be responsible for the decrease of
[Ca2+]c induced by AngII: 1) an inhibition of the
calcium influx through voltage-operated calcium channels, or 2) an
activation of the pumping of calcium out of the cytosol through plasma
membrane Ca2+/Mg2+-ATPases. In order to
discriminate between these possibilities, we completely blocked the
Ca2+ channels opened by K+ with 2 µM nifedipine, before the addition of AngII (Fig.
1B). As expected, an almost complete inhibition of the
sustained [Ca2+]c response to K+ was
observed upon addition of nifedipine, and AngII exerted only a very
small effect on the residual [Ca2+]c level
thereafter, thus excluding a strong activation of the Ca2+
pumps by the hormone and therefore privileging an action of AngII on
the dihydropyridine-sensitive Ca2+ channels.
Inhibition of L-type Currents by AngII--
Single bovine
glomerulosa cells were voltage-clamped in the permeabilized patch
configuration of the patch clamp technique and both T- and L-type
Ca2+ channels were activated upon a step depolarization
from 90 to 0 mV. In order to discriminate between T and L currents,
we maintained the depolarized state at 0 mV for 600 ms (Fig.
2, inset). L current was
measured after 500 ms, when most T channels are inactivated, as
expected according to their fast inactivation characteristics (time
constant, = 20 ms at 0 mV) and when T current amplitude is
therefore negligible.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Inhibition of L-type currents by AngII in
bovine glomerulosa cells. Ba2+ currents were recorded
from a single voltage-clamped glomerulosa cell maintained in the
perforated patch configuration of the patch clamp technique, as
described in detail under "Experimental Procedures." Currents were
elicited every 30 s by a step depolarization from 90 to 0 mV for
600 ms and L-type current amplitudes were measured after 500 ms, when
T-type current contribution is negligible. Inset, example of
currents from the same cell and elicited before (control)
and after the addition of AngII (100 nM) and nifedipine (1 µM). Data are representative of 14 independently tested
cells.
|
|
A time-course study of L-type current amplitude (Fig. 2) confirmed its
relative stability in the perforated patch configuration. Addition of
100 nM AngII induced a marked inhibition of the current in
less than 1 min. Addition of a dihydropyridine antagonist, such as
nifedipine or nicardipine, at the end of the experiment blocked the
residual current and pharmacologically confirmed the identity of this
current. The mean inhibition induced by AngII has been estimated to be
63 ± 11% (n = 14) of the maximal current, a
value closely related to the inhibition of the
[Ca2+]c signal.
In contrast, the transient current observed during the first 50 ms
depolarization and reflecting T channel activity remained unaffected by
AngII or nifedipine treatment at 0 mV. Moreover, it is noteworthy that
the action of AngII on L current was only rarely observed in the whole
cell configuration and that the cells needed to be maintained
metabolically intact (in the perforated patch configuration) for AngII
to exert its inhibition on L channels.
Washing out the hormone (Fig. 3) allowed
recovery of 30 ± 3% of L channel activity (n = 3), whereas addition of losartan (10 µM), a specific
AT1 receptor antagonist, a few minutes after the hormone
reversed only 19 ± 5% of the AngII effect (n = 4). This lack of complete reversibility could be attributed to AngII
receptor sequestration or endocytosis, as previously suggested by
Ambroz and Catt (19).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Reversibility and voltage dependence of L
current inhibition. Ba2+ currents were recorded from a
single voltage-clamped glomerulosa cell as described in the legend of
Fig. 2, and the inhibition induced by AngII was reversed by washing out
the hormone from the medium. A, example of trace recordings
obtained before (1) or after (2) the addition of
100 nM AngII and after washing out the hormone
(3). B, the current-voltage relationship of the
L-type Ba2+ current was established under each condition by
varying the amplitude of the step depolarization. C, time
course of L-current variations induced by AngII or during wash out.
Numbers indicate the times at which current-voltage curves
were determined and correspond to numbers in A and
B.
|
|
Fig. 3B also shows the current-voltage relationship of the
L-type current before ( ) and after ( ) the addition of 100 nM AngII, as well as after the wash-out of the hormone
( ). The inhibition of the current exerted by the hormone was
observed at any voltage, and AngII did not change the shape of the
current-voltage curve; threshold, peak, and reversal potentials of the
Ba2+ current were not affected by AngII (n = 6).
Losartan Prevents the Inhibition of L-type Current by
AngII--
We have previously shown that the presence of
losartan (DuP753), prevents the action of AngII on the
[Ca2+]c signal induced by extracellular
K+ (10). Similarly, losartan prevented AngII action on
L-type channels. Indeed, as illustrated in Fig.
4, losartan (10 µM) had no
effect by itself on the amplitude of L-type currents elicited by a
depolarization to 0 mV but completely prevented the AngII-induced inhibition of this current (n = 4). The current
remained sensitive to dihydropyridines and was almost completely
abolished upon addition of 2 µM nicardipine.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Inhibition by losartan of the AngII effect on
the L-current. The amplitude of L current elicited before and
after the addition of AngII (100 nM) and nicardipine (2 µM) was determined as described in the legend of Fig. 2,
but in the presence of losartan (10 µM). This result is
representative of four independent experiments.
|
|
To further characterize the molecular mechanism through which AngII
exerts its inhibition on L currents, we tested whether protein kinase C
(PKC), which is coupled to the AT1 receptor through the
formation of diacylglycerol, is involved in the modulation of L-type
channels. We have previously shown that in glomerulosa cells, T-type
channels are negatively regulated by PKC and that aldosterone
production is concomitantly reduced (10, 20); however, we have also
demonstrated that activation of PKC with the phorbol ester phorbol
12-myristate 13-acetate is unable to mimic AngII action on the
[Ca2+]c signal induced by K+
(13). In agreement with the latter observation, phorbol 12-myristate 13-acetate had no effect on L-type currents and did not prevent the
inhibition induced by AngII in 4 individually tested cells (data not shown).
The inhibition of L-type Current by AngII Is Sensitive to Pertussis
Toxin Treatment--
In numerous cells, it has been shown that L-type
calcium channels can be modulated by pertussis toxin-sensitive G
proteins, such as Gi or Go (21). We therefore
treated bovine glomerulosa cells overnight with 500 ng/ml pertussis
toxin (Ptx) before recording L-type currents. Under these conditions,
we observed a marked reduction of the inhibition of L-type
Ca2+ channels in response to AngII. Fig.
5 shows a cell in which AngII effect on
L-type current was completely abolished by Ptx treatment, although the
sensitivity to dihydropyridines remained unchanged. On average, the
inhibition of the current elicited by AngII, which amounted to 63% in
control cells, was reduced to only 21 ± 17% after treatment with
Ptx (n = 16). The effect of Ptx was statistically significant according to an unpaired Student's t test with
a p value < 0.0001.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Pertussis toxin treatment prevents AngII
action on L current. Glomerulosa cells were treated overnight with
500 ng/ml pertussis toxin before being tested as described in the
legend of Fig. 2. Inset, examples of currents recorded from
the same cell and elicited before (control) and after the
addition of AngII (100 nM) and nicardipine (2 µM). Data are representative of 16 independently tested
cells.
|
|
Effect of Pertussis Toxin Treatment on AngII Action on the
Cytosolic Ca2+ Signal and on Aldosterone Secretion--
In
order to determine whether the effect of Ptx on the AngII-induced
inhibition observed on Ba2+ currents is also exerted on
[Ca2+]c homeostasis, we performed
Ca2+ microfluorometry experiments in single fura-2-loaded
glomerulosa cells. Fig. 6 compares the
[Ca2+]c fluctuations obtained in a control cell
(A) and in a cell treated overnight with Ptx (500 ng/ml)
(B). Cells were successively exposed to thapsigargin,
K+, and AngII, as described in Fig. 1A. After
establishment of an elevated plateau of [Ca2+]c
at approximately 400 nM with K+, the addition
of AngII led to a dramatic reduction of the
[Ca2+]c signal in the control cell (Fig.
6A), but had a much less pronounced effect in the
Ptx-treated cell (Fig. 6B). The responses obtained in
control individual cells (n = 3) were similar to those
obtained in control cell populations (Fig. 1A);
AngII-induced inhibition of the [Ca2+]c signal
amounted on average to 60 ± 5%. In contrast, in the Ptx-treated
single cells, the inhibition of the K+-induced
[Ca2+]c elevation by AngII was reduced to only
19 ± 8% in the five tested cells.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of pertussis toxin on the
[Ca2+]c response to AngII in single adrenal
glomerulosa cells. Cultured cells were incubated overnight in the
absence (A) or in the presence (B) of 500 ng/ml
Ptx before to be loaded with the fluorescent calcium probe fura-2.
Variations of cytosolic calcium in single glomerulosa cells were
recorded (as described under "Experimental Procedures") upon
addition of thapsigargin (200 nM), KCl (9 mM),
and AngII (100 nM).
|
|
In a separate series of experiments, we have assessed the effect of Ptx
treatment on the [Ca2+]c response to AngII at a
low concentration of K+ (3 mM). Under these
conditions, the [Ca2+]c rise induced by AngII,
measured during the plateau phase 3 min after hormone addition, was
slightly more pronounced in Ptx-treated cells (93 ± 16 nM, n = 10) as compared with control cells
(69 ± 11 nM, n = 12, data not shown),
probably reflecting a lack of L channel inhibition in Ptx-treated cells.
Because treatment with Ptx maintains [Ca2+]c at
markedly higher levels upon stimulation with AngII, we have
investigated the effect of Ptx on the steroidogenic response. As
illustrated in Fig. 7, pretreatment with
the toxin reduced by approximately 20% the aldosterone secretion
evoked by AngII, without significantly changing the EC50
value for the hormone. Similar results were obtained when aldosterone
was stimulated with increasing concentrations of AngII in the presence
of 9 mM instead of 3 mM K+ (not
shown).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of pertussis toxin on the
steroidogenic response to AngII. Cultured cells were incubated
overnight in the presence or in the absence (control) of 500 ng/ml Ptx, before being exposed for 1 h at 37 °C to increasing
concentrations of AngII. Potassium concentration in the medium amounted
to 3 mM. Aldosterone production was determined in the
medium by direct radioimmunoassay as described under "Experimental
Procedures" and is expressed per mg of cell protein. Aldosterone
secretion was significantly reduced in Ptx-treated as compared with
control cells at AngII concentrations above 1 nM
(p < 0.05, according to a paired Student's
t test). Data are the mean values from four independent
experiments performed in duplicate and were fitted to four parameter
logistic functions; half-maximal stimulation was obtained at 1.5 and
3.0 nM AngII for control and Ptx-treated cells,
respectively.
|
|
Identification of G Protein Isoforms Expressed in Bovine
Glomerulosa Cells--
Because both Go and Gi
proteins are known to be sensitive to Ptx, we have investigated which
isoform is expressed in bovine adrenal glomerulosa cells. The presence
of Go and Gi in cellular extracts was analyzed
by SDS-PAGE and immunoblotting with specific antibodies raised against
the subunit of each isoform. Results were compared with those
obtained with the GH4C1 rat pituitary cell
line, in which the expression of these isoforms has been well
characterized (22).
As expected, both Go and Gi isoforms were
detected in GH4C1 cells as strong bands at
approximately 40 kDa (Fig. 8). Bands of
similar intensity were also observed in proteins extracts of bovine
adrenal glomerulosa cells, strongly suggesting that both Gi
and Go proteins are constitutively expressed in these
cells.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 8.
Identification of G protein subtypes
expressed in bovine adrenal glomerulosa cells by immunoblotting
analysis. Proteins from cultured bovine adrenal glomerulosa
(BAG) cells and from GH4C1 cells
were extracted and separated by SDS-PAGE, as described under
"Experimental Procedures." Proteins (16 µg/lane) were then
transferred onto a cellulose membrane to be analyzed for the presence
of specific G proteins with rat polyclonal antibodies raised against
the subunits of the Go and Gi proteins.
Arrows indicate the position of markers with relative
molecular masses of 29 and 45 kDa. Similar results were obtained in
four independent preparations.
|
|
 |
DISCUSSION |
The aim of the present study was to characterize the molecular
mechanism by which AngII exerts its inhibitory action on the cytosolic
Ca2+ response to K+ (Fig. 1A), a
phenomenon already observed several years ago in adrenal glomerulosa
cells (5). Because this effect disappeared after voltage-operated
calcium channel inhibition with dihydropyridines (Fig. 1B),
it is deduced that the reduction of [Ca2+]c
evoked by AngII reflects the hormonal modulation of these channels
rather than an activation of Ca2+ extrusion from the
cytosol. In previous work (10), we have studied the modulation by AngII
of the low threshold T-type calcium channels, which appeared, at this
time, to be the main effectors of Ca2+ entry under very
small depolarizations resulting from physiological K+
increases. More recently, we have focused our attention on the high
threshold L-type channels for two reasons: 1) the inhibition of the
steady-state current flowing through T-type channels with phorbol
12-myristate 13-acetate is not accompanied by a reduction of the
[Ca2+]c levels; and 2) the
[Ca2+]c response to low concentrations of
extracellular K+ is mainly due to L-type channels, the
contribution of T channels to the signal being negligible (13).
The main finding of the present work is that AngII clearly modulates
negatively L channels in bovine adrenal glomerulosa cells, to the same
extent as it reduces [Ca2+]c. This inhibition
does not result from a shift of the sensitivity of the channel to
voltage and is observed at any membrane potential; however, further
investigation will be required, particularly at the single channel
level, in order to determine whether total current inhibition is due to
a decrease of channel open probability, to a change of channel
conductance or to a modulation of channel insertion within the plasma
membrane. In any case, these results strongly suggest that the
inhibition of L-type channels by AngII is responsible for the decreased
[Ca2+]c.
The AT1 receptor subtype has been shown to be the major
AngII receptor expressed in adrenal glomerulosa cells and to mediate most of the hormone actions in these cells (23). The AngII-induced inhibition of L-type Ca2+ channels appears to be also
mediated by the AT1 receptor. Indeed, the presence of the
AT1-selective antagonist losartan completely abolished
AngII action (Fig. 4). This result is in agreement with the previous
observation that losartan also prevents the action of AngII on the
sustained [Ca2+]c response to K+
(10).
Various cellular mechanisms of L-type Ca2+ channel
modulation have been extensively investigated (21). From these studies, two major pathways have been highlighted: these involve either GTP
binding proteins or channel phosphorylation by specific kinases. Whereas a role for PKC or tyrosine kinases, enzymes known to be linked
to AT1 receptor activation, could be recently excluded (24), we show here (Fig. 5) that the modulation of the L-type current
by AngII is much reduced after pertussis toxin treatment. This finding
strongly suggests that the transduction of the AngII signal from the
AT1 receptor to the L-type channels involves a Ptx-sensitive G protein of the Gi/Go family.
A modulation of L channels by AngII through G proteins has been
previously observed in other cell types, but with contrasting results.
For example, Hescheler et al. (25) have demonstrated that
AngII, through a Gi protein, stimulates L-type current in the murine adrenocortical cell line Y1. More recently, an inhibition by
AngII of L-type currents has been reported in rabbit sinoatrial node
cells (26) as well as in guinea pig cardiomyocytes (27), and these
negative modulations have been proposed to be mediated by
Gi through an inhibition of the cAMP-dependent
pathway. Moreover, in each of these studies, pretreatment of the cells
with Ptx abolished AngII action on L currents. It is, however,
noteworthy that in contrast to what we observed in glomerulosa cells,
in the above studies, AngII affected L currents only after they had
been enhanced by -adrenergic stimulation, the hormone being
inefficient on basal currents.
As expected, in bovine adrenal glomerulosa cells, Ptx treatment also
markedly reduced the AngII-induced inhibition of the sustained
[Ca2+]c response to K+ (Fig. 6) and
slightly increased the [Ca2+]c response to AngII
itself (not shown). This sensitivity of the
[Ca2+]c signal to Ptx confirms the previously
described close relationship existing between
[Ca2+]c and L-type channel activity (13) and
strongly reinforces the hypothesis that L channels are principally
responsible for the variations of [Ca2+]c
observed upon stimulation of glomerulosa cells with physiological
concentrations of extracellular K+.
Surprisingly, despite the fact that Ptx treatment maintained higher
levels of [Ca2+]c upon stimulation with AngII,
aldosterone production was significantly reduced (Fig. 7). This result
suggests that either the negative feedback exerted by AngII on the
[Ca2+]c signal induced by K+, or
another factor controlled by a Ptx-sensitive G protein, is required for
an optimal steroidogenic response. Relevant to this point is the
suggestion by Barrett et al. (12) that Ca2+
influx through L-type channels could exert a negative action on the
steroidogenic function of bovine glomerulosa cells.
Nevertheless, because pertussis toxin also negatively affects
aldosterone production at relatively low [Ca2+]c
(expected to occur at basal extracellular K+ and
concentrations of AngII as low as 0.1 nM; see Fig. 7), a bell-shaped dependence of steroidogenesis upon calcium is probably not
the only explanation, and some still undetermined steroidogenic factor,
controlled by a pertussis toxin-sensitive G protein, could also be
involved in this phenomenon.
In rat glomerulosa cells, it has been shown that Ptx treatment helps
AngII to maintain an optimal aldosterone secretion at supramaximal
concentrations of the hormone but has no effect at lower AngII
concentrations (28). This specific effect of Ptx in rat cells is
presumably due to prevention of adenylyl cyclase inhibition by AngII
through a Gi protein, although contradictory results in
this species have been published by others (29, 30). In bovine
glomerulosa cells, Barrett and Isales (31) have previously observed a
20% inhibition of the steroidogenic response to 10 nM
AngII after treatment with Ptx, a result that is in complete agreement
with our own observation (Fig. 7).
Both Gi and Go proteins appear to be expressed
in bovine adrenal glomerulosa cells (Fig. 8), but pertussis toxin does
not allow to discriminate between the respective functions of each of
these proteins. Nevertheless, in other cell types, Go
proteins have been generally shown to negatively modulate L-type
channels, whereas in contrast, Gi protein activation is
often associated with a direct (cAMP-independent) increase of the
activity of these channels (21, 25, 32). Furthermore, we and others
have recently shown that in bovine glomerulosa cells, AngII does not
inhibit but rather potentiates cAMP production (33, 34), suggesting a
poor coupling between the AT1 receptor and some
Gi protein in these cells. These two facts would therefore
indirectly favor the involvement of a Go protein in the
negative modulation of L-type channels by AngII in bovine glomerulosa cells.
In conclusion, the negative modulation of [Ca2+]c
homeostasis exerted by AngII in bovine adrenal glomerulosa cells reflects the inhibition of L-type Ca2+ channels by this
hormone. Moreover, the inhibition of these channels involves a
Ptx-sensitive G protein, presumably of the Go family, linked to the AT1 receptor subtype (Fig.
9). It therefore appears that the same
hormone, through the same receptor, is able to inhibit different types
of Ca2+ channels in the cell through distinct mechanisms: T
channel activity is negatively modulated through PKC activation,
whereas L channels are partially closed via a Ptx-sensitive G protein.
This differential control by AngII of Ca2+ entry occurring
through various channels should probably represent an advantage for the
cell in view of the growing evidence that different types of
Ca2+ channels exert distinct functions in glomerulosa
cells.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 9.
Model describing the modulation of
voltage-operated calcium channels by AngII in bovine adrenal
glomerulosa cells. The abbreviations used are as follows:
AT1, angiotensin II receptor subtype 1; DAG,
diacylglycerol; G, GTP-binding protein; L and
T, voltage-operated calcium channels of types L and T;
PLC, phosphoinositide-specific phospholipase C.
|
|
 |
ACKNOWLEDGEMENTS |
We are particularly grateful to G. Dorenter
and W. Dimeck for excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grants 32-49297.96, 31-42178.94, and 31-52779.97.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed. Tel.: 41-22-3729320;
Fax: 41-22-3729329; E-mail: rossier@cmu.unige.ch.
 |
ABBREVIATIONS |
The abbreviations used are:
AngII, angiotensin
II;
PAGE, polyacrylamide gel electrophoresis;
Ptx, pertussis toxin;
PKC, protein kinase C.
 |
REFERENCES |
| 1.
|
Burnay, M. M.,
Python, C. P.,
Vallotton, M. B.,
Capponi, A. M.,
and Rossier, M. F.
(1994)
Endocrinology
135,
751-758[Abstract]
|
| 2.
|
Capponi, A. M.,
Python, C. P.,
and Rossier, M. F.
(1994)
Endocrine
2,
579-586
|
| 3.
|
Barrett, P. Q.,
Isales, C. M.,
Bollag, W. B.,
and McCarthy, R. T.
(1991)
Am. J. Physiol.
261,
F706-F719[Abstract/Free Full Text]
|
| 4.
|
Capponi, A. M.,
and Rossier, M. F.
(1996)
Curr. Opin. Endocrinol. Diabetes
3,
248-257
|
| 5.
|
Capponi, A. M.,
Lew, P. D.,
and Vallotton, M. B.
(1987)
Biochem. J.
247,
335-340[Medline]
[Order article via Infotrieve]
|
| 6.
|
Balla, T.,
Hollo, Z.,
Varnai, P.,
and Spät, A.
(1991)
Biochem. J.
273,
399-404
|
| 7.
|
Matsunaga, H.,
Yamashita, N.,
Maruyama, Y.,
Kojima, I.,
and Kurokawa, K.
(1987)
Biochem. Biophys. Res. Commun.
149,
1049-1054[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Cohen, C. J.,
McCarthy, R. T.,
Barrett, P. Q.,
and Rasmussen, H.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
2412-2416[Abstract/Free Full Text]
|
| 9.
|
Lu, H.-K.,
Fern, R. J.,
Luthin, D.,
Linden, J.,
Liu, L.-P.,
Cohen, C. J.,
and Barrett, P. Q.
(1996)
Am. J. Physiol.
271,
C1340-C1349[Abstract/Free Full Text]
|
| 10.
|
Rossier, M. F.,
Aptel, H. B. C.,
Python, C. P.,
Burnay, M. M.,
Vallotton, M. B.,
and Capponi, A. M.
(1995)
J. Biol. Chem.
270,
15137-15142[Abstract/Free Full Text]
|
| 11.
|
Rossier, M. F.,
Burnay, M. M.,
Brandenburger, Y.,
Cherradi, N.,
Vallotton, M. B.,
and Capponi, A. M.
(1996)
Endocr. Res.
22,
579-588[Medline]
[Order article via Infotrieve]
|
| 12.
|
Barrett, P. Q.,
Ertel, E. A.,
Smith, M. M.,
Nee, J. J.,
and Cohen, C. J.
(1995)
Am. J. Physiol.
268,
C985-C992[Abstract/Free Full Text]
|
| 13.
|
Rossier, M. F.,
Burnay, M. M.,
Vallotton, M. B.,
and Capponi, A. M.
(1996)
Endocrinology
137,
4817-4826[Abstract]
|
| 14.
|
Rossier, M. F.,
Python, C. P.,
Capponi, A. M.,
Schlegel, W.,
Kwan, C. Y.,
and Vallotton, M. B.
(1993)
Endocrinology
132,
1035-1043[Abstract/Free Full Text]
|
| 15.
|
Rossier, M. F.,
Burnay, M. M.,
and Capponi, A. M.
(1998)
in
Low Voltage-activated T-type Calcium Channels
(Clozel, J.-P.
, Nargeot, J.
, and Tsien, R. W., eds)
, pp. 176-185, Adis International, Chester, United Kingdom
|
| 16.
|
Horn, R.,
and Marty, A.
(1988)
J. Gen. Physiol.
92,
145-159[Abstract/Free Full Text]
|
| 17.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 18.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Ambroz, C.,
and Catt, K. J.
(1992)
Endocrinology
131,
408-414[Abstract/Free Full Text]
|
| 20.
|
Aptel, H. B. C.,
Johnson, E. I. M.,
Vallotton, M. B.,
Rossier, M. F.,
and Capponi, A. M.
(1996)
Mol. Cell. Endocrinol.
119,
105-111[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Hescheler, J.,
and Schulz, G.
(1993)
Curr. Opin. Neurobiol.
3,
360-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Yajima, Y.,
Akita, Y.,
Katada, T.,
and Saito, T.
(1993)
Mol. Cell. Endocrinol.
92,
143-152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Balla, T.,
Baukal, A. J.,
Eng, S.,
and Catt, K. J.
(1991)
Mol. Pharmacol.
40,
401-406[Abstract]
|
| 24.
|
Maturana, A. D.,
Burnay, M. M.,
Capponi, A. M.,
Vallotton, M. B.,
and Rossier, M. F.
(1999)
J. Recept. Signal Transduction Res.
19,
509-520[Medline]
[Order article via Infotrieve]
|
| 25.
|
Hescheler, J.,
Rosenthal, W.,
Hinsch, K.-D.,
Wulfern, M.,
Trautwein, W.,
and Schulz, G.
(1988)
EMBO J.
7,
619-624[Medline]
[Order article via Infotrieve]
|
| 26.
|
Habuchi, Y.,
Lu, L. L.,
Morikawa, J.,
and Yoshimura, M.
(1995)
Am. J. Physiol.
268,
H1053-H1060[Abstract/Free Full Text]
|
| 27.
|
Ai, T.,
Horie, M.,
Obayashi, K.,
and Sasayama, S.
(1998)
Pfluegers Arch. Eur. J. Physiol.
436,
168-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Hausdorff, W. P.,
Sekura, R. D.,
Aguilera, G.,
and Catt, K. J.
(1987)
Endocrinology
120,
1668-1678[Abstract/Free Full Text]
|
| 29.
|
Woodcock, E. A.,
and McLeod, J. K.
(1986)
Endocrinology
119,
1697-1702[Abstract/Free Full Text]
|
| 30.
|
Gallo-Payet, N.,
Chouinard, L.,
Balestre, M.-N.,
and Guillon, G.
(1991)
Mol. Cell. Endocrinol.
81,
11-23[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Barrett, P. Q.,
and Isales, C. M.
(1988)
Endocrinology
122,
799-808[Abstract/Free Full Text]
|
| 32.
|
Degtiar, V. E.,
Harhammer, R.,
and Nurnberg, B.
(1997)
J. Physiol.
502,
321-333[Abstract/Free Full Text]
|
| 33.
|
Baukal, A. J.,
Hunyady, L.,
Catt, K. J.,
and Balla, T.
(1994)
J. Biol. Chem.
269,
24546-24549[Abstract/Free Full Text]
|
| 34.
|
Burnay, M. M.,
Vallotton, M. B.,
Capponi, A. M.,
and Rossier, M. F.
(1998)
Biochem. J.
330,
21-27
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. D. Maturana, S. Walchli, M. Iwata, S. Ryser, J. Van Lint, M. Hoshijima, W. Schlegel, Y. Ikeda, K. Tanizawa, and S. Kuroda
Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel
Cardiovasc Res,
June 1, 2008;
78(3):
458 - 465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Hunyady and K. J. Catt
Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II
Mol. Endocrinol.,
May 1, 2006;
20(5):
953 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gambaryan, E. Butt, P. Tas, A. Smolenski, B. Allolio, and U. Walter
Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP
Am J Physiol Endocrinol Metab,
March 1, 2006;
290(3):
E423 - E433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Feng, Y. Ding, S. Ren, L. Zhou, C. Xu, and S. S. Karnik
Unconventional Homologous Internalization of the Angiotensin II Type-1 Receptor Induced by G-Protein-Independent Signals
Hypertension,
August 1, 2005;
46(2):
419 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Enyeart, S. J. Danthi, and J. J. Enyeart
TREK-1 K+ channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells
Am J Physiol Endocrinol Metab,
December 1, 2004;
287(6):
E1154 - E1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev,
April 1, 2004;
84(2):
489 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Charbonneau, M. Leclerc, and M. G. Brunette
Effect of angiotensin II on calcium reabsorption by the luminal membranes of the nephron
Am J Physiol Endocrinol Metab,
June 1, 2001;
280(6):
E928 - E936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ceolotto, R. Valente, E. Baritono, S. Reato, E. Iori, A. Monari, R. Trevisan, and A. Semplicini
Effect of Insulin and Angiotensin II on Cell Calcium in Human Skin Fibroblasts
Hypertension,
June 1, 2001;
37(6):
1486 - 1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev.,
September 1, 2000;
52(3):
415 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|